| 1. | | Recruiting | Intraperitoneal Floxuridine in Gastric Carcinoma
Condition: Stomach Neoplasms |
| 2. | | Recruiting | Tezacitabine with or without 5-Fluorouracil (5-FU) for advanced esophageal cancer or gastric cancer
Conditions: Esophageal Neoplasms; Stomach Neoplasms; Adenocarcinoma |
| 3. | | Recruiting | Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction
Conditions: Cancer of Stomach; Gastroesophageal Cancer |
| 4. | | Recruiting | S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
Conditions: stage IV gastric cancer; adenocarcinoma of the stomach |
| 5. | | Recruiting | Intravenous Edotecarin in Patients with Advanced Gastric Cancer that has Progressed or Recurred After Prior Fluoropyrimidine-based Chemotherapy
Condition: Gastric Cancer |
| 6. | | Recruiting | Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Metastatic or Inoperable Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (Cancer)
Conditions: Esophageal Cancer; Gastric Cancer |
| 7. | | Recruiting | Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Conditions: stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach |
| 8. | | Recruiting | Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
Conditions: adenocarcinoma of the stomach; stage III gastric cancer; stage IV gastric cancer |
| 9. | | Recruiting | Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Conditions: recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach |
| 10. | | Recruiting | Phase 1/2 study of S-1 and cisplatin in advanced gastric cancer
Condition: Gastric Cancer |
| 11. | | Recruiting | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Conditions: unspecified adult solid tumor, protocol specific; stage IV esophageal cancer; stage IV gastric cancer |
| 12. | | Recruiting | Imatinib Mesylate in Treating Patients With Refractory Metastatic and/or Unresectable Stomach Cancer
Conditions: recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach |
| 13. | | Recruiting | Oblimersen, Cisplatin, and Fluorouracil in Treating Patients With Advanced Esophageal, Gastroesophageal Junction, or Stomach Cancer
Conditions: Esophageal Cancer; Gastric Cancer |
| 14. | | Recruiting | Neoadjuvant Irinotecan and Cisplatin Followed By Surgical Resection in Treating Patients With Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
Conditions: adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer |
| 15. | | Recruiting | Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer
Conditions: recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach |
| 16. | | Recruiting | Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
Conditions: adenocarcinoma of the stomach; recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer |
| 17. | | Recruiting | Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction
Conditions: adenocarcinoma of the stomach; Adenocarcinoma of the Esophagus; stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; ... |
| 18. | | Recruiting | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Conditions: Esophageal Cancer; Gastric Cancer |
| 19. | | Recruiting | Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
Conditions: Esophageal Cancer; Gastric Cancer |
| 20. | | Recruiting | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
Conditions: recurrent breast cancer; recurrent gastric cancer; recurrent non-small cell lung cancer; recurrent ovarian epithelial cancer; ... |
| 21. | | Recruiting | Vaccine Therapy in Treating Patients With Gastric Cancer, Non-Small Cell Lung Cancer, Prostate, or Ovarian Cancer
Conditions: adult brain tumor; Gastric Cancer; Non-small cell lung cancer; ovarian epithelial cancer; Prostate Cancer |
| 22. | | Recruiting | Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Conditions: stage III gastric cancer; stage II esophageal cancer; stage III esophageal cancer; adenocarcinoma of the stomach; ... |
| 23. | | Recruiting | LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
Conditions: Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Pancreatic Cancer |
| 24. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach
Conditions: Esophageal Cancer; Gastric Cancer |
| 25. | | Recruiting | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
Conditions: stage II gastric cancer; stage III gastric cancer |
| 26. | | Recruiting | Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
Conditions: stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer |
